Loss of FBXO31-mediated degradation of DUSP6 dysregulates ERK and PI3K-AKT signaling and promotes prostate tumorigenesis

Authors:

Abstract
No abstract available
Funding Information
  • Howard Hughes Medical Institute
  • National Institutes of Health (R35-GM136250)
  • National Institutes of Health (R01-CA76584)
  • National Institutes of Health (2T32CA009161)
  • National Research Council (70126)
  • LAM Therapeutics

This publication has 75 references indexed in Scilit: